Show simple item record

dc.contributor.authorWalter, Jan
dc.contributor.authorHaller, Sebastian
dc.contributor.authorQuinten, Chantal
dc.contributor.authorKärki, Tommi
dc.contributor.authorZacher, Benedikt
dc.contributor.authorEckmanns, Tim
dc.contributor.authorAbu Sin, Muna
dc.contributor.authorPlachouras, Diamantis
dc.contributor.authorKinross, Pete
dc.contributor.authorSuetens, Carl
dc.date.accessioned2018-11-19T11:44:29Z
dc.date.available2018-11-19T11:44:29Z
dc.date.issued2018
dc.identifier.citationHealthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012. 2018, 23 (32) Euro Surveill.en
dc.identifier.issn1560-7917
dc.identifier.pmid30107871
dc.identifier.doi10.2807/1560-7917.ES.2018.23.32.1700843
dc.identifier.urihttp://hdl.handle.net/10029/622237
dc.description.abstractAn aim of the ECDC point prevalence survey (PPS) in European Union/European Economic Area acute care hospitals was to acquire standardised healthcare-associated infections (HAI) data. We analysed one of the most common HAIs in the ECDC PPS, healthcare-associated pneumonia (HAP). Standardised HAI case definitions were provided and countries were advised to recruit nationally representative subsets of hospitals. We calculated 95% confidence intervals (CIs) around prevalence estimates and adjusted for clustering at hospital level. Of 231,459 patients in the survey, 2,902 (1.3%; 95% CI: 1.2-1.3) fulfilled the case definition for a HAP. HAPs were most frequent in intensive care units (8.1%; 95% CI: 7.4-8.9) and among patients intubated on the day of the survey (15%; 95% CI: 14-17; n = 737 with HAP). The most frequently reported microorganism was Pseudomonas aeruginosa (17% of 1,403 isolates), followed by Staphylococcus aureus (12%) and Klebsiella spp. (12%). Antimicrobial resistance was common among isolated microorganisms. The most frequently prescribed antimicrobial group was penicillins, including combinations with beta-lactamase inhibitors. HAPs occur regularly among intubated and non-intubated patients, with marked differences between medical specialities. HAPs remain a priority for preventive interventions, including surveillance. Our data provide a reference for future prevalence of HAPs at various settings.
dc.language.isoenen
dc.rightsArchived with thanks to Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletinen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleHealthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012.en
dc.typeArticleen
dc.identifier.journalEurosurveillance 2018; 23(32):pii.1700843en
refterms.dateFOA2018-12-18T14:35:28Z
html.description.abstractAn aim of the ECDC point prevalence survey (PPS) in European Union/European Economic Area acute care hospitals was to acquire standardised healthcare-associated infections (HAI) data. We analysed one of the most common HAIs in the ECDC PPS, healthcare-associated pneumonia (HAP). Standardised HAI case definitions were provided and countries were advised to recruit nationally representative subsets of hospitals. We calculated 95% confidence intervals (CIs) around prevalence estimates and adjusted for clustering at hospital level. Of 231,459 patients in the survey, 2,902 (1.3%; 95% CI: 1.2-1.3) fulfilled the case definition for a HAP. HAPs were most frequent in intensive care units (8.1%; 95% CI: 7.4-8.9) and among patients intubated on the day of the survey (15%; 95% CI: 14-17; n = 737 with HAP). The most frequently reported microorganism was Pseudomonas aeruginosa (17% of 1,403 isolates), followed by Staphylococcus aureus (12%) and Klebsiella spp. (12%). Antimicrobial resistance was common among isolated microorganisms. The most frequently prescribed antimicrobial group was penicillins, including combinations with beta-lactamase inhibitors. HAPs occur regularly among intubated and non-intubated patients, with marked differences between medical specialities. HAPs remain a priority for preventive interventions, including surveillance. Our data provide a reference for future prevalence of HAPs at various settings.


Files in this item

Thumbnail
Name:
eurosurv-23-32-3.pdf
Size:
229.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Archived with thanks to Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Except where otherwise noted, this item's license is described as Archived with thanks to Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin